Jason R Westin (Jason Westin)

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 65

Top Topics

Hodgkin Lymphoma

Diffuse Large B Cell Lymphoma

Tyrosine Kinase

Top Venues

British journal of haematology

Leukemia & lymphoma

American journal of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Matthew A Lunning, Hai-Lin Wang, Zhen-Huan Hu, Frederick L Locke, Tanya Siddiqi, Caron A Jacobson, Sairah Ahmed, David B Miklos, Yi Lin, Brian T Hill, Armin Ghobadi, Sattva S Neelapu, Jason R Westin, Chrisopher Dieyi, Polly Field, Harry Miao, Shilpa A Shahani, Anik Patel, Clare Spooner, Christine Fu, David Muramoto, Hairong Xu, Marcelo C Pasquini
Benefit of axicabtagene ciloleucel versus chemoimmunotherapy in older patients and/or patients with poor ECOG performance status with relapsed or refractory large B-cell lymphoma after 2 or more lines of prior therapy. American journal of hematology 99 (5) (2024)
Chijioke Nze, Clark R Andersen, Amy Ayers, Jason R Westin, Michael L Wang, Swaminathan P Iyer, Sairah A Ahmed, Chelsea C Pinnix, Francisco Vega, Lynne Nguyen, Lorna McNeill, Loretta J Nastoupil, Kehe Zhang, Cici X Bauer, Christopher R Flowers
Impact of Demographics and Neighborhood Socioeconomic Variables on Clinical Trial Participation in Non-Hodgkin Lymphoma. Blood advances (2024)
Armin Ghobadi, Javier Munoz, Jason R Westin, Frederick L Locke, David Bernard Miklos, Aaron P Rapoport, Miguel-Ángel Perales, Patrick M Reagan, Joseph P McGuirk, Caron A Jacobson, Marie José Kersten, Irit Avivi, Andrew Peng, Marco Schupp, Christina To, Olalekan O Oluwole
Outcomes of subsequent antilymphoma therapies after second-line axicabtagene ciloleucel or standard of care in ZUMA-7. Blood advances 8 (11) (2024)
Matthew A Lunning, Hai-Lin Wang, Zhen-Huan Hu, Frederick L Locke, Tanya Siddiqi, Caron A Jacobson, Sairah Ahmed, David B Miklos, Yi Lin, Brian T Hill, Armin Ghobadi, Sattva S Neelapu, Jason R Westin, Chrisopher Dieyi, Polly Field, Harry Miao, Shilpa A Shahani, Anik Patel, Clare Spooner, Christine Fu, David Muramoto, Hairong Xu, Marcelo C Pasquini
Benefit of axicabtagene ciloleucel versus chemoimmunotherapy in older patients and/or patients with poor ECOG performance status with relapsed or refractory large B-cell lymphoma after 2 or more lines of prior therapy. American journal of hematology (2024)
Armin Ghobadi, Javier L Muñoz, Jason R Westin, Frederick L Locke, David Bernard Miklos, Aaron P Rapoport, Miguel-Ángel Perales, Patrick M Reagan, Joseph P McGuirk, Caron A Jacobson, Marie José Kersten, Irit Avivi, Andrew Peng, Marco Schupp, Christina To, Olalekan O Oluwole
Outcomes of subsequent anti-lymphoma therapies after second-line axicabtagene ciloleucel or standard of care in ZUMA-7. Blood advances (2024)
Chijioke Nze, Clark R Andersen, Amy A Ayers, Jason R Westin, Michael L Wang, Swaminathan Iyer, Sairah A Ahmed, Chelsea Pinnix, Francisco Vega, Lynne Nguyen, Lorna McNeill, Loretta J Nastoupil, Kehe Zhang, Cici X Bauer, Christopher R Flowers
Impact of patient demographics and neighborhood socioeconomic variables on clinical trial participation patterns for NHL. Blood advances 8 (14) (2024)
Michael D Jain, Jay Y Spiegel, Loretta J Nastoupil, John S Tamaresis, Armin Ghobadi, Yi Lin, Lazaros Lekakis, Patrick Reagan, Olalekan O Oluwole, Joseph P McGuirk, Abhinav Deol, Kathleen A Dorritie, Alison R Sehgal, Andre H Goy, Brian T Hill, Charalambos Andreadis, Javier L Muñoz, Matthew L Ulrickson, Jason R Westin, Julio C Chavez, Dilan A Patel, Miriam T Jacobs, Radhika Bansal, N Nora Bennani, Vivek G Patel, Aaron P Rapoport, Julie M Vose, David Bernard Miklos, Sattva S Neelapu, Frederick L Locke, Matthew Lunning, Saurabh Dahiya
Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Armin Ghobadi, Javier Munoz, Jason R Westin, Frederick L Locke, David Bernard Miklos, Aaron P Rapoport, Miguel-Ángel Perales, Patrick M Reagan, Joseph P McGuirk, Caron A Jacobson, Marie José Kersten, Irit Avivi, Andrew Peng, Marco Schupp, Christina To, Olalekan O Oluwole
Outcomes of subsequent antilymphoma therapies after second-line axicabtagene ciloleucel or standard of care in ZUMA-7. Blood advances 8 (11) (2024)
Michael D Jain, Jay Y Spiegel, Loretta J Nastoupil, John S Tamaresis, Armin Ghobadi, Yi Lin, Lazaros Lekakis, Patrick Reagan, Olalekan O Oluwole, Joseph P McGuirk, Abhinav Deol, Kathleen A Dorritie, Alison R Sehgal, Andre H Goy, Brian T Hill, Charalambos Andreadis, Javier L Muñoz, Matthew L Ulrickson, Jason R Westin, Julio C Chavez, Dilan A Patel, Miriam T Jacobs, Radhika Bansal, N Nora Bennani, Vivek G Patel, Aaron P Rapoport, Julie M Vose, David Bernard Miklos, Sattva S Neelapu, Frederick L Locke, Matthew Lunning, Saurabh Dahiya
Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Matthew A Lunning, Hai-Lin Wang, Zhen-Huan Hu, Frederick L Locke, Tanya Siddiqi, Caron A Jacobson, Sairah Ahmed, David B Miklos, Yi Lin, Brian T Hill, Armin Ghobadi, Sattva S Neelapu, Jason R Westin, Chrisopher Dieyi, Polly Field, Harry Miao, Shilpa A Shahani, Anik Patel, Clare Spooner, Christine Fu, David Muramoto, Hairong Xu, Marcelo C Pasquini
Benefit of axicabtagene ciloleucel versus chemoimmunotherapy in older patients and/or patients with poor ECOG performance status with relapsed or refractory large B-cell lymphoma after 2 or more lines of prior therapy. American journal of hematology 99 (5) (2024)
Chijioke Nze, Clark R Andersen, Amy A Ayers, Jason R Westin, Michael L Wang, Swaminathan Iyer, Sairah A Ahmed, Chelsea Pinnix, Francisco Vega, Lynne Nguyen, Lorna McNeill, Loretta J Nastoupil, Kehe Zhang, Cici X Bauer, Christopher R Flowers
Impact of patient demographics and neighborhood socioeconomic variables on clinical trial participation patterns for NHL. Blood advances 8 (14) (2024)
Armin Ghobadi, Javier Munoz, Jason R Westin, Frederick L Locke, David Bernard Miklos, Aaron P Rapoport, Miguel-Ángel Perales, Patrick M Reagan, Joseph P McGuirk, Caron A Jacobson, Marie José Kersten, Irit Avivi, Andrew Peng, Marco Schupp, Christina To, Olalekan O Oluwole
Outcomes of subsequent antilymphoma therapies after second-line axicabtagene ciloleucel or standard of care in ZUMA-7. Blood advances 8 (11) (2024)
Matthew A Lunning, Hai-Lin Wang, Zhen-Huan Hu, Frederick L Locke, Tanya Siddiqi, Caron A Jacobson, Sairah Ahmed, David B Miklos, Yi Lin, Brian T Hill, Armin Ghobadi, Sattva S Neelapu, Jason R Westin, Chrisopher Dieyi, Polly Field, Harry Miao, Shilpa A Shahani, Anik Patel, Clare Spooner, Christine Fu, David Muramoto, Hairong Xu, Marcelo C Pasquini
Benefit of axicabtagene ciloleucel versus chemoimmunotherapy in older patients and/or patients with poor ECOG performance status with relapsed or refractory large B-cell lymphoma after 2 or more lines of prior therapy. American journal of hematology 99 (5) (2024)
Chijioke Nze, Clark R Andersen, Amy A Ayers, Jason R Westin, Michael L Wang, Swaminathan Iyer, Sairah A Ahmed, Chelsea Pinnix, Francisco Vega, Lynne Nguyen, Lorna McNeill, Loretta J Nastoupil, Kehe Zhang, Cici X Bauer, Christopher R Flowers
Impact of patient demographics and neighborhood socioeconomic variables on clinical trial participation patterns for NHL. Blood advances 8 (14) (2024)
Armin Ghobadi, Javier Munoz, Jason R Westin, Frederick L Locke, David Bernard Miklos, Aaron P Rapoport, Miguel-Ángel Perales, Patrick M Reagan, Joseph P McGuirk, Caron A Jacobson, Marie José Kersten, Irit Avivi, Andrew Peng, Marco Schupp, Christina To, Olalekan O Oluwole
Outcomes of subsequent antilymphoma therapies after second-line axicabtagene ciloleucel or standard of care in ZUMA-7. Blood advances 8 (11) (2024)
Matthew A Lunning, Hai-Lin Wang, Zhen-Huan Hu, Frederick L Locke, Tanya Siddiqi, Caron A Jacobson, Sairah Ahmed, David B Miklos, Yi Lin, Brian T Hill, Armin Ghobadi, Sattva S Neelapu, Jason R Westin, Chrisopher Dieyi, Polly Field, Harry Miao, Shilpa A Shahani, Anik Patel, Clare Spooner, Christine Fu, David Muramoto, Hairong Xu, Marcelo C Pasquini
Benefit of axicabtagene ciloleucel versus chemoimmunotherapy in older patients and/or patients with poor ECOG performance status with relapsed or refractory large B-cell lymphoma after 2 or more lines of prior therapy. American journal of hematology 99 (5) (2024)
Simone Filosto, Saran Vardhanabhuti, Miguel A Canales, Xavier Poire, Lazaros J Lekakis, Sven de Vos, Craig A Portell, Zixing Wang, Christina To, Marco Schupp, Soumya Poddar, Tan Trinh, Carmen M Warren, Ethan G Aguilar, Justin Budka, Paul Cheng, Justin Chou, Adrian Bot, Rhine R Shen, Jason R Westin
Product attributes of CAR T-cell therapy differentially associate with efficacy and toxicity in second-line large B-cell lymphoma (ZUMA-7). Blood cancer discovery (2023)
Paolo Strati, Andrew P Jallouk, Qing Deng, Xubin Li, Lei Feng, Ryan Sun, Sherry Adkins, Swapna Johncy, Taylor Cain, Raphael E Steiner, Sairah A Ahmed, Dai Chihara, Luis E Fayad, Swaminathan P Iyer, Sandra B Horowitz, Loretta J Nastoupil, Ranjit Nair, Ahmed Hassan, Taher Daoud, Misha Hawkins, Maria A Rodriguez, Elizabeth J Shpall, Jeremy Leon Ramdial, Partow Kebriaei, David S Hong, Jason R Westin, Sattva S Neelapu, Michael R Green
A Phase I Study of Prophylactic Anakinra to Mitigate ICANS in Patients with Large B-cell Lymphoma. Blood advances (2023)
Christoph K Stein-Thoeringer, Neeraj Y Saini, Eli Zamir, Viktoria Blumenberg, Maria-Luisa Schubert, Uria Mor, Matthias A Fante, Sabine Schmidt, Eiko Hayase, Tomo Hayase, Roman Rohrbach, Chia-Chi Chang, Lauren McDaniel, Ivonne Flores, Rogier Gaiser, Matthias Edinger, Daniel Wolff, Martin Heidenreich, Paolo Strati, Ranjit Nair, Dai Chihara, Luis E Fayad, Sairah Ahmed, Swaminathan P Iyer, Raphael E Steiner, Preetesh Jain, Loretta J Nastoupil, Jason R Westin, Reetakshi Arora, Michael L Wang, Joel Turner, Meghan Menges, Melanie Hidalgo-Vargas, Kayla Reid, Peter Dreger, Anita Schmitt, Carsten Muller-Tidow, Frederick L Locke, Marco L Davila, Richard E Champlin, Christopher R Flowers, Elizabeth J Shpall, Hendrik Poeck, Sattva S Neelapu, Michael Schmitt, Marion Subklewe, Michael D Jain, Robert R Jenq, Eran Elinav
A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy. Nature medicine (2023)
Jason R Westin, Olalekan O Oluwole, Marie José Kersten, David B Miklos, Miguel-Angel Perales, Armin Ghobadi, Aaron P Rapoport, Anna Sureda, Caron A Jacobson, Umar Farooq, Tom van Meerten, Matthew Ulrickson, Mahmoud Elsawy, Lori A Leslie, Sridhar Chaganti, Michael J Dickinson, Kathleen Dorritie, Patrick M Reagan, Joseph McGuirk, Kevin W Song, Peter A Riedell, Monique C Minnema, Yin Yang, Saran Vardhanabhuti, Simone Filosto, Paul Cheng, Shilpa A Shahani, Marco Schupp, Christina To, Frederick L Locke, null null
Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma. The New England journal of medicine (2023)
Adam J Olszewski, Tycel Jovelle Phillips, Marc S Hoffmann, Philippe Armand, Tae Min Kim, Dok Hyun Yoon, Amitkumar Mehta, Richard Greil, Jason R Westin, Izidore S Lossos, Javier L Muñoz, Jason Sit, Michael C Wei, Annie Yang, Vivian Chen, Enkhtsetseg Purev, Donald L Yee, Ulrich Jäger
Mosunetuzumab in combination with CHOP in previously untreated DLBCL: safety and efficacy results from a phase 2 study. Blood advances (2023)
Ashwath Gurumurthi, Jason R Westin, Marion Subklewe
The race is on: bispecifics vs CAR T-cells in B-cell lymphoma. Blood advances (2023)
Anath C Lionel, Jason R Westin
Evolving Role of CAR T Cell Therapy in First- and Second-Line Treatment of Large B Cell Lymphoma. Current oncology reports (2023)
Jason R Westin, Frederick L Locke, Michael J Dickinson, Armin Ghobadi, Mahmoud Elsawy, Tom van Meerten, David Bernard Miklos, Matthew L Ulrickson, Miguel-Ángel Perales, Umar Farooq, Luciano Wannesson, Lori A Leslie, Marie José Kersten, Caron A Jacobson, John M Pagel, Gerald Georg Wulf, Patrick B Johnston, Aaron P Rapoport, Linqiu Du, Saran Vardhanabhuti, Simone Filosto, Jina Shah, Julia Thornton Snider, Paul Cheng, Christina To, Olalekan O Oluwole, Anna Sureda
Safety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Hua-Jay J Cherng, Jason R Westin
Broadening the MIND: Tafasitamab and Lenalidomide versus Synthetic Controls. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (18) (2022)
Mario L Marques-Piubelli, Edwin R Parra, Lei Feng, Luisa Maren Solis Soto, Mariana Gallardo, Sushanth Gouni, Felipe Samaniego, Mansoor Noorani, Fredrick B Hagemeister, Jason R Westin, Hun Ju Lee, Maria A Rodriguez, Sattva S Neelapu, Jillian R Gunther, Nathan H Fowler, Christopher R Flowers, Ignacio I Wistuba, Loretta J Nastoupil, Francisco Vega, Paolo Strati
SIRPα+ macrophages are increased in patients with FL who progress or relapse after frontline lenalidomide and rituximab. Blood advances 6 (11) (2022)
Ulrich Jäger, Constantine S Tam, Peter Borchmann, Joseph P McGuirk, Marianne Johansen, Edmund K Waller, Samantha M Jaglowski, Charalambos Andreadis, Stephen R Foley, Jason R Westin, Isabelle Fleury, P Joy Ho, Stephan Mielke, Takanori Teshima, Gilles Andre Salles, Stephen J Schuster, Fiona He, Richard T Maziarz, Sebastian Mayer, Shinichi Makita, Marie J Kersten, Monalisa Ghosh, Nina D Wagner-Johnston, Koji Kato, Paolo Corradini, Hideki Goto, Silvia Colicino, Abhijit Agarwal, Chiara Lobetti-Bodoni, Michael R Bishop
Long-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma. Blood advances 6 (16) (2022)
R Andrew Harkins, Sharvil Piyush Patel, Michelle J Lee, Jeffrey M Switchenko, Stephen M Ansell, Nancy L Bartlett, Kristie A Blum, Amanda F Cashen, Carla Casulo, Jonathan W Friedberg, Patrick B Johnston, Brad S Kahl, John P Leonard, Brian L Link, Izidore S Lossos, Peter Martin, Matthew John Maurer, Neha Mehta-Shah, Patrick M Reagan, Jason R Westin, Jean L Koff, Christopher R Flowers
Improving eligibility criteria for first-line trials for patients with DLBCL using a US-based Delphi-method survey. Blood advances 6 (9) (2022)
Hua-Jay Jeffery Cherng, Stefan Alig, Yasuhiro Oki, Loretta J Nastoupil, Luis E Fayad, Sattva S Neelapu, Francesco Turturro, Fredrick B Hagemeister, Alexander Craig, Charles W Macaulay, Maria A Rodriguez, Hun Ju Ju Lee, Timothy McDonnell, Christopher R Flowers, Francisco Vega, Michael R Green, Lei Feng, David M Kurtz, Ash A Alizadeh, Richard Eric Davis, Jason R Westin
A phase 1/2 study of lenalidomide and obinutuzumab with CHOP for newly diagnosed DLBCL. Blood advances (2022)
Max J Gordon, Anna Sureda, Jason R Westin
Novel strategies for relapsed/refractory DLBCL; navigating the immunotherapy era in aggressive lymphoma. Leukemia & lymphoma 63 (9) (2022)
Jason R Westin
Always be prepared for success. Blood 139 (13) (2022)
Serkan Akin, Chitra Hosing, Issa Khouri, Sairah A Ahmed, Amin Alousi, Nathan Fowler, Jacinth Joseph, Jonathan Truxillo, Jeremy L Ramdial, Farzaneh Maadani, Gabriela Rondon, May Daher, Jin S Im, Raphael E Steiner, Jason R Westin, Swaminathan P Iyer, Bouthaina Dabaja, Paolo Anderlini, Uday R Popat, Muzaffar H Qazilbash, Christopher R Flowers, Elizabeth Shpall, Richard E Champlin, Yago L Nieto, Samer A Srour
Autologous stem cell transplantation for large B-cell lymphoma with secondary central nervous system involvement. Blood advances 6 (7) (2022)
Loretta J Nastoupil, Collin K Chin, Jason R Westin, Nathan H Fowler, Felipe Samaniego, Xiaoyun Cheng, Man Chun John Ma, Zhiqiang Wang, Fuliang Chu, Ly Dsouza, Chizobam Obi, Jennifer Mims, Lei Feng, Shouhao Zhou, Michael Green, Richard Eric Davis, Sattva S Neelapu
Safety and activity of pembrolizumab in combination with rituximab in relapsed or refractory follicular lymphoma. Blood advances 6 (4) (2022)
Jason R Westin, R Eric Davis, Lei Feng, Fredrick B Hagemeister, Raphael Steiner, Jee Hun Lee, Luis Fayad, Loretta Nastoupil, Sairah Ahmed, Maria A Rodriguez, Michelle Fanale, Felipe Samaniego, Swaminathan P Iyer, Ranjit Nair, Yasuhiro Oki, Nathan Fowler, Michael L Wang, Man Chun John Ma, Francisco Vega, Timothy McDonnell, Chelsea Pinnix, Donna Griffith, Yang Lu, Sanjit O Tewari, Ryan Sun, David W Scott, Christopher R Flowers, Sattva S Neelapu, Michael R Green
Smart Start: Rituximab, Lenalidomide, and Ibrutinib in Patients With Newly Diagnosed Large B-Cell Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Ajlan Al Zaki, Lei Feng, Grace Watson, Sairah A Ahmed, Haleigh Mistry, Loretta J Nastoupil, Misha Hawkins, Ranjit Nair, Swaminathan P Iyer, Hun J Lee, Raphael E Steiner, Christopher R Flowers, Elizabeth J Shpall, Partow Kebriaei, Sattva S Neelapu, Jason R Westin, Paolo Strati
Day 30 SUVmax predicts progression in patients with lymphoma achieving PR/SD after CAR T-cell therapy. Blood advances 6 (9) (2022)
Neeraj Y Saini, David M Swoboda, Uri Greenbaum, Junsheng Ma, Romil D Patel, Kartik Devashish, Kaberi Das, Mark R Tanner, Paolo Strati, Ranjit Nair, Luis Fayad, Sairah A Ahmed, Hun Ju Lee, Swaminathan P Iyer, Raphael E Steiner, Nitin Jain, Loretta Nastoupil, Sanam Loghavi, Guilin Tang, Roland L Bassett, Preetesh Jain, Michael L Wang, Jason R Westin, Michael R Green, David A Sallman, Eric Padron, Marco L Davila, Frederick L Locke, Richard E Champlin, Guillermo Garcia-Manero, Elizabeth J Shpall, Partow Kebriaei, Christopher R Flowers, Michael D Jain, Feng Wang, Andrew P Futreal, Nancy Gillis, Sattva S Neelapu, Koichi Takahashi
Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma. Blood cancer discovery 3 (5) (2022)
Guangchun Han, Qing Deng, Mario L Marques-Piubelli, Enyu Dai, Minghao Dang, Man Chun John Ma, Xubin Li, Haopeng Yang, Jared Henderson, Olga Mikhaylovna Plotnikova, Mark Meerson, Sergey Isaev, Nikita Kotlov, Krystle J Nomie, Alexander V Bagaev, Edwin Roger Parra Cuentes, Luisa Maren Solis Soto, Simrit Parmar, Fredrick B Hagemeister, Sairah A Ahmed, Swaminathan P Iyer, Felipe Samaniego, Raphael E Steiner, Luis Fayad, Jee Hun Lee, Nathan Hale Fowler, Christopher R Flowers, Paolo Strati, Jason R Westin, Sattva S Neelapu, Loretta J Nastoupil, Francisco Vega, Linghua Wang, Michael R Green
Follicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and MHC Class II Expression. Blood cancer discovery 3 (5) (2022)
Jason R Westin, Laurie Helen Sehn
CAR T cells as a second-line therapy for large B-cell lymphoma: a paradigm shift? Blood 139 (18) (2022)
Hua-Jay J Cherng, Ryan Sun, Bryant Sugg, Russell Irwin, Haopeng Yang, Cuong Cao Le, Qing Deng, Luis Fayad, Nathan H Fowler, Simrit Parmar, Raphael E Steiner, Fredrick Hagemeister, Ranjit Nair, Hun Ju Lee, Maria A Rodriguez, Felipe Samaniego, Swaminathan P Iyer, Christopher R Flowers, Linghua Wang, Loretta J Nastoupil, Sattva S Neelapu, Sairah A Ahmed, Paolo Strati, Michael R Green, Jason R Westin
Risk assessment with low-pass whole-genome sequencing of cell-free DNA before CD19 CAR T-cell therapy for large B-cell lymphoma. Blood 140 (5) (2022)
Jason R Westin, Marie José Kersten, Gilles Salles, Jeremy S Abramson, Stephen J Schuster, Frederick L Locke, Charalambos Andreadis
Efficacy and safety of CD19-directed CAR-T cell therapies in patients with relapsed/refractory aggressive B-cell lymphomas: Observations from the JULIET, ZUMA-1, and TRANSCEND trials. American journal of hematology 96 (10) (2021)
Max J Gordon, Jason R Westin
Fitting double-hit lymphoma into the aggressive lymphoma spectrum: a square peg in a round hole? Leukemia & lymphoma (2021)
Karine A Al Feghali, Penny Fang, Maria Gule-Monroe, Sarah Milgrom, Joseph D Khoury, Jillian R Gunther, Tommy Sheu, Ranjit Nair, Sairah Ahmed, Raphael E Steiner, Paolo Strati, Elizabeth J Shpall, Yago L Nieto, Chitra Hosing, Loretta J Nastoupil, Jason R Westin, Sattva S Neelapu, Nathan Hale Fowler, Christopher Flowers, Chelsea C Pinnix, Bouthaina S Dabaja
Prognostic value of disease distribution in secondary central nervous system diffuse large B cell lymphoma treated with radiation therapy. Leukemia & lymphoma 62 (10) (2021)
David M Kurtz, Joanne Soo, Lyron Co Ting Keh, Stefan K Alig, Jacob J Chabon, Brian J Sworder, Andre Schultz, Michael C Jin, Florian Scherer, Andrea Garofalo, Charles W Macaulay, Emily G Hamilton, Binbin Chen, Mari Olsen, Joseph G Schroers-Martin, Alexander F M Craig, Everett J Moding, Mohammad S Esfahani, Chih Long Liu, Ulrich Dührsen, Andreas Huettmann, René-Olivier Casasnovas, Jason R Westin, Mark J Roschewski, Wyndham H Wilson, Gianluca Gaidano, Davide Rossi, Maximillian Diehn, Ash A Alizadeh
Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA. Nature biotechnology (2021)
Michael R Bishop, Michael Dickinson, Duncan Purtill, Pere Barba, Armando Santoro, Nada Hamad, Koji Kato, Anna Sureda, Richard Greil, Catherine Thieblemont, Franck Morschhauser, Martin Janz, Ian Flinn, Werner Rabitsch, Yok-Lam Kwong, Marie J Kersten, Monique C Minnema, Harald Holte, Esther H L Chan, Joaquin Martinez-Lopez, Antonia M S Müller, Richard T Maziarz, Joseph P McGuirk, Emmanuel Bachy, Steven Le Gouill, Martin Dreyling, Hideo Harigae, David Bond, Charalambos Andreadis, Peter McSweeney, Mohamed Kharfan-Dabaja, Simon Newsome, Evgeny Degtyarev, Rakesh Awasthi, Christopher Del Corral, Giovanna Andreola, Aisha Masood, Stephen J Schuster, Ulrich Jäger, Peter Borchmann, Jason R Westin
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma. The New England journal of medicine 386 (7) (2021)
Hua-Jay J Cherng, Jason R Westin
Why R-CHOP + X is not enough: lessons learned and next steps in the mission to improve frontline therapy for diffuse large B-cell lymphoma. Leukemia & lymphoma 62 (6) (2021)
Hua-Jay J Cherng, Hubert H Chuang, Raphael E Steiner, Luis Fayad, Paolo Strati, Ranjit Nair, Fredrick Hagemeister, Loretta J Nastoupil, Hun Ju Lee, Sattva S Neelapu, Christopher R Flowers, Felipe Samaniego, Maria Rodriguez, Homer A Macapinlac, Lei Feng, Jason R Westin
A prospective study on early PET/CT scans during the first cycle of salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma. Leukemia & lymphoma (2021)
Paolo Strati, Sairah A Ahmed, Fateeha Furqan, Luis E Fayad, Hun J Lee, Swaminathan P Iyer, Ranjit Nair, Loretta J Nastoupil, Simrit Parmar, Maria A Rodriguez, Felipe Samaniego, Raphael E Steiner, Michael L Wang, Chelsea C Pinnix, Sandra B Horowitz, Lei Feng, Ryan Sun, Catherine M Claussen, Misha C Hawkins, Nicole A Johnson, Prachee Singh, Haleigh Mistry, Swapna Johncy, Sherry Adkins, Partow Kebriaei, Elizabeth J Shpall, Michael R Green, Christopher R Flowers, Jason R Westin, Sattva S Neelapu
Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma. Blood 137 (23) (2021)
Alexander Augustyn, L Jeffrey Medeiros, Ethan Bernard Ludmir, Jillian Gunther, Penny Fang, Shaoying Li, Chi Young Ok, Mikaela E Bankston, Vivek Verma, Dario Pasalic, Sairah Ahmed, Loretta J Nastoupil, Jason R Westin, Paolo Strati, Sattva S Neelapu, Ranjit Nair, Raphael E Steiner, Swaminathan P Iyer, Alma Rodriguez, Luis E Fayad, Christopher R Flowers, Bouthaina S Dabaja, Chelsea C Pinnix
The impact of cell-of-origin, MYC/Bcl-2 dual expression and MYC rearrangement on disease relapse among early stage diffuse large B-cell lymphoma patients treated with combined modality therapy. Leukemia & lymphoma 62 (6) (2021)
Uri Greenbaum, Paolo Strati, Rima M Saliba, Janet Torres, Gabriela Rondon, Yago L Nieto, Chitra Hosing, Samer A Srour, Jason R Westin, Luis E Fayad, Hun J Lee, Swaminathan P Iyer, Ranjit Nair, Loretta J Nastoupil, Simrit Parmar, Maria A Rodriguez, Felipe Samaniego, Raphael E Steiner, Michael L Wang, Chelsea C Pinnix, Christopher R Flowers, Sudhakar Tummala, Jeremy L Ramdial, Fevzi F Yalniz, Misha Hawkins, Katayoun Rezvani, Richard E Champlin, Elizabeth J Shpall, Sattva S Neelapu, Partow Kebriaei, Sairah A Ahmed
CRP and ferritin in addition to the EASIX score predict CAR-T-related toxicity. Blood advances 5 (14) (2021)
Loretta J Nastoupil, Sattva S Neelapu, Richard Eric Davis, Felipe Samaniego, Nathan Hale Fowler, Jason R Westin, Hun Ju Lee, Michael L Wang, Fredrick Hagemeister, Alexander R L Cecil, James Dow, Kemal Haque, Franck A Silva, Andrew Whale, Letitia Lensun, Elisabeth A Bone, Hilary McElwaine-Johnn, Philip A Beer
Preclinical and phase I studies of KA2237, a selective and potent inhibitor of PI3K β/δ in relapsed refractory B cell lymphoma. Leukemia & lymphoma (2021)
Frederick L Locke, David B Miklos, Caron A Jacobson, Miguel-Angel Perales, Marie-José Kersten, Olalekan O Oluwole, Armin Ghobadi, Aaron P Rapoport, Joseph McGuirk, John M Pagel, Javier Muñoz, Umar Farooq, Tom van Meerten, Patrick M Reagan, Anna Sureda, Ian W Flinn, Peter Vandenberghe, Kevin W Song, Michael Dickinson, Monique C Minnema, Peter A Riedell, Lori A Leslie, Sridhar Chaganti, Yin Yang, Simone Filosto, Jina Shah, Marco Schupp, Christina To, Paul Cheng, Leo I Gordon, Jason R Westin, null null
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma. The New England journal of medicine (2021)
Stefan K Alig, Charles W Macaulay, David M Kurtz, Ulrich Dührsen, Andreas Huettmann, Christine Schmitz, Michael C Jin, Brian J Sworder, Andrea Garofalo, Mohammad Shahrokh Esfahani, Barzin Y Nabet, Joanne Soo, Florian Scherer, Alexander F M Craig, René-Olivier Casasnovas, Jason R Westin, Gianluca Gaidano, Davide Rossi, Mark J Roschewski, Wyndham H Wilson, Michel Meignan, Maximilian Diehn, Ash A Alizadeh
Short Diagnosis-to-Treatment Interval Is Associated With Higher Circulating Tumor DNA Levels in Diffuse Large B-Cell Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (23) (2021)
Chelsea C Pinnix, Sarah A Milgrom, Chan Yoon Cheah, Jillian R Gunther, Ethan Bernard Ludmir, Christine F Wogan, Loretta J Nastoupil, Sattva S Neelapu, Jason R Westin, Hun J Lee, Swaminathan P Iyer, Raphael E Steiner, Luis E Fayad, Nathan H Fowler, Michael L Wang, Felipe Samaniego, Maria A Rodriguez, Amy E Rich, L Jeffrey Medeiros, Bouthaina S Dabaja
Favorable outcomes with de-escalated radiation therapy for limited-stage nodular lymphocyte-predominant Hodgkin lymphoma. Blood advances 3 (9) (2020)
Jason R Westin
Ibrutinib and lenalidomide: when 1+1 = >2. Blood 134 (13) (2020)
Michael R Bishop, Richard T Maziarz, Edmund K Waller, Ulrich Jäger, Jason R Westin, Joseph P McGuirk, Isabelle Fleury, Harald Holte, Peter Borchmann, Christopher Del Corral, Ranjan Tiwari, Özlem Anak, Rakesh Awasthi, Lida Pacaud, Vadim V Romanov, Stephen J Schuster
Tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma patients without measurable disease at infusion. Blood advances 3 (14) (2020)
Neeraj Jain, Keenan T Hartert, Saber Tadros, Warren C Fiskus, Ondrej Havranek, Man Chun John Ma, Alyssa Bouska, Tayla Heavican, Dhiraj Kumar, Qing Deng, Dalia Moore, Christine Pak, Chih Long Liu, Andrew J Gentles, Elena Gerhard-Hartmann, Robert Kridel, Karin Ekstrom Smedby, Gunnar Juliusson, Richard Rosenquist, Randy D Gascoyne, Andreas Rosenwald, Filippo G Giancotti, Sattva S Neelapu, Jason R Westin, Julie M Vose, Matthew A Lunning, Timothy C Greiner, Scott J Rodig, Javeed Iqbal, Ash A Alizadeh, Richard Eric Davis, Kapil N Bhalla, Michael R Green
Targetable genetic alterations of TCF4 (E2-2) drive immunoglobulin expression in diffuse large B cell lymphoma. Science translational medicine 11 (497) (2020)
Dai Chihara, Yasuhiro Oki, Michelle A Fanale, Jason R Westin, Loretta J Nastoupil, Sattva Neelapu, Luis Fayad, Nathan H Fowler, Chan Y Cheah
Stage I Non-Hodgkin Lymphoma: difference in survival outcome by primary extranodal site of involvement. British journal of haematology 185 (2) (2018)
Michelle A Fanale, Chan Yoon Y Cheah, Amy Rich, L Jeffrey Medeiros, Chao-Ming Lai, Yasuhiro Oki, Jorge E Romaguera, Luis E Fayad, F B Hagemeister, Felipe Samaniego, Maria A Rodriguez, Sattva S Neelapu, Hun J Lee, Loretta J Nastoupil, Nathan Hale Fowler, Francesco Turturro, Jason R Westin, Michael L Wang, Peter McLaughlin, Chelsea C Pinnix, Sarah A Milgrom, Bouthaina Shbib Dabaja, Sandra B Horowitz, Anas Younes
Encouraging activity for R-CHOP in advanced stage nodular lymphocyte-predominant Hodgkin lymphoma. Blood 130 (4) (2017)
Preetesh Jain, Rashmi Kanagal-Shamanna, F Anthony San Lucas, Loretta Nastoupil, Jorge Romaguera, Luis Fayad, Yasuhiro Oki, Jason R Westin, Leonard Jeffrey Medeiros, Michael Wang, Nathan Fowler
Clinicopathological characteristics, outcomes and pattern of mutations in patients with follicular lymphoma who progressed on Bruton tyrosine kinase inhibitors. British journal of haematology 182 (5) (2017)
Loretta J Nastoupil, Peter McLaughlin, Lei Feng, Sattva S Neelapu, Felipe Samaniego, Fredrick B Hagemeister, Ana Ayala, Jorge E Romaguera, Andre H Goy, Eleanor Neal, Michael Wang, Luis Fayad, Michelle A Fanale, Yasuhiro Oki, Jason R Westin, Maria A Rodriguez, Fernando Cabanillas, Nathan H Fowler
High ten-year remission rates following rituximab, fludarabine, mitoxantrone and dexamethasone (R-FND) with interferon maintenance in indolent lymphoma: Results of a randomized Study. British journal of haematology 177 (2) (2017)
Natalie Galanina, Sonali M Smith, Chuanhong Liao, Adam Petrich, Bernadette Libao, Ronald Gartenhaus, Jason R Westin, Kenneth S Cohen, James A Knost, Walter M Stadler, Austin Doyle, Theodore Karrison, Leo I Gordon, Andrew M Evens
University of Chicago phase II consortium trial of selumetinib (MEKi) demonstrates low tolerability and efficacy in relapsed DLBCL. British journal of haematology 181 (2) (2017)
Yiming Chen, Sattva Neelapu, Lei Feng, Weiqi Bi, Tian-Hui Yang, Michael Wang, Michelle A Fanale, Jason R Westin, Fredrick B Hagemeister, Luis E Fayad, Jorge E Romaguera, Felipe Samaniego, Francesco Turturro, Nathan H Fowler, Peter McLaughlin, Fernando Cabanillas, Yasuhiro Oki, Loretta J Nastoupil, Alma Rodriguez
Prognostic significance of baseline peripheral absolute neutrophil, monocyte and serum β2-microglobulin level in patients with diffuse large b-cell lymphoma: a new prognostic model. British journal of haematology 175 (2) (2016)
Dai Chihara, Jason R Westin, Roberto N Miranda, Chan Y Cheah, Yasuhiro Oki, Francesco Turturro, Jorge E Romaguera, Sattva S Neelapu, Lorreta J Nastoupil, Luis E Fayad, M Alma Rodriguez, Nathan H Fowler, Robert Z Orlowski, Michael Wang, Fredrick B Hagemeister, L Jeffrey Medeiros, Michelle A Fanale
Dose adjusted-EPOCH-R and mediastinal disease may improve outcomes for patients with gray-zone lymphoma. British journal of haematology 179 (3) (2016)
Dai Chihara, Nathan H Fowler, Yasuhiro Oki, Michelle A Fanale, Luis E Fayad, Jason R Westin, Fredrick B Hagemeister
Dose-Adjusted EPOCH-R and Mid-Cycle High Dose Methotrexate for Patients with Systemic Lymphoma and secondary CNS Involvement. British journal of haematology 179 (5) (2016)
Dai Chihara, Michelle A Fanale, Roberto N Miranda, Mansoor Noorani, Jason R Westin, Loretta J Nastoupil, Fredrick B Hagemeister, Luis E Fayad, Jorge E Romaguera, Felipe Samaniego, Francesco Turturro, Hun J Lee, Sattva S Neelapu, M Alma Rodriguez, Michael Wang, Nathan H Fowler, Richard E Davis, L Jeffrey Medeiros, Chitra Hosing, Yago L Nieto, Yasuhiro Oki
The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma. British journal of haematology 176 (5) (2016)
Dai Chihara, Chan Yoon Y Cheah, Jason R Westin, Luis E Fayad, Maria A Rodriguez, Fredrick B Hagemeister, Barbara Pro, Peter McLaughlin, Anas Younes, Felipe Samaniego, Andre Goy, Fernando Cabanillas, Hagop Kantarjian, Larry W Kwak, Michael L Wang, Jorge E Romaguera
Rituximab plus hyper-CVAD alternating with MTX/Ara-C in patients with newly diagnosed mantle cell lymphoma: 15-year follow-up of a phase II study from the MD Anderson Cancer Center. British journal of haematology 172 (1) (2015)